Cytoreductive Surgery (CRS) and Heated Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Mesothelioma: Canadian Practices and Outcomes.

Melina Deban,Kadhim Taqi,Gregory C. Knapp,Mikael Soucisse, Matt Curry,Lucas Sideris,Pierre Dube,Maher Al Khaldi, Nicole Jedrzejko,Geoff Porter,Carman Giacomantonio,Trevor Hamilton,Andrea MacNeill,Lloyd Mack,Antoine Bouchard-Fortier

JOURNAL OF SURGICAL ONCOLOGY（2023）

引用 1|浏览0

暂无评分

摘要

Peritoneal mesothelioma (PM) is a rare malignancy originating from the peritoneal lining. Cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) is the standard‐of‐care for patients with isolated PM. Due to a paucity of prospective data there are several different HIPEC protocols. The aims of this study are to describe the CRS and HIPEC protocols for PM and patient outcomes across Canada.

查看译文

关键词

Hyperthermic Intraperitoneal Chemotherapy,Intraperitoneal Chemotherapy,Cytoreductive Surgery

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要